| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.32 | 0.004 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |